Inflammatory bowel disease and risk of severe COVID‐19: A nationwide population‐based cohort study in Sweden

BACKGROUND: There are concerns that individuals with chronic immune‐mediated diseases are at increased risk of COVID‐19 and related severe adverse outcome, including intensive care admission or death. We aimed to explore the absolute and relative risk of severe COVID‐19 in inflammatory bowel disease...

Descripción completa

Detalles Bibliográficos
Autores principales: Ludvigsson, Jonas F., Axelrad, Jordan, Halfvarson, Jonas, Khalili, Hamed, Larsson, Emma, Lochhead, Paul, Roelstraete, Bjorn, Simon, Tracey G., Söderling, Jonas, Olén, Ola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Covid
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014882/
https://www.ncbi.nlm.nih.gov/pubmed/33704918
http://dx.doi.org/10.1002/ueg2.12049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014882/
https://www.ncbi.nlm.nih.gov/pubmed/33704918
http://dx.doi.org/10.1002/ueg2.12049

Ejemplares similares